Patents

  • Use of a compound, pharmaceutical formulation, method of treating asthma and COPD, and/or, compound. 2022, Brazil. Patent: Innovation Privilege. Register Number: PCT/BR2022/05004, Institution of registration: RO/BR. Deposit: 02/11/2022.
  • Hybrid compounds (2-cyano-3-(indol-3-yl)-phenylacrylamide with immunomodulator, anti-inflammatory and analgesic potential. 2019, Brazil. Patent: Innovation Privilege. Register Number: BR10201902032, Institution of registration: INPI - National Institute of Industrial Property. Deposit: 09/27/2019.